#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3694	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2216	476.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1711	1711	T	520	T	483	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3694	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2216	476.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1445	1445	C	506	C	452	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5728	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4164	411.8	0	.	n	.	0	T695C	SNP	695	695	T	1387	1387	C	408	C,T	361,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5728	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4164	411.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	2029	2029	A	452	A,G	412,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5728	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4164	411.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2330	2330	G	502	G,A	447,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5728	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4164	411.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2663	2663	C	545	C,T	480,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5728	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4164	411.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2737	2737	A	559	A	519	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5728	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4164	411.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3289	3289	C	509	C,T	458,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	484	folP	855	855	100.0	folP.l15.c4.ctg.1	1925	74.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1209	1211	AGC	110;110;109	A;G;C	100;99;98	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1076	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3807	84.7	1	SNP	p	S91F	1	.	.	271	273	TTC	808	810	TTC	82;82;82	T;T;C	75;77;76	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1076	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3807	84.7	1	SNP	p	D95G	1	.	.	283	285	GGC	820	822	GGC	83;85;83	G;G;C	79;80;77	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1076	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3807	84.7	1	SNP	p	G95N	0	.	.	283	285	GGC	820	822	GGC	83;85;83	G;G;C	79;80;77	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	514	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1941	79.5	1	SNP	p	G45D	0	.	.	133	135	GGC	853	855	GGC	130;128;130	G;G;C	121;121;122	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	332	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1486	67.1	0	.	n	.	0	A197.	DEL	197	197	A	845	845	A	124	A	115	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1206	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3414	106.0	1	SNP	p	D86N	0	.	.	256	258	GAC	755	757	GAC	113;113;113	G;A;C	104;102;104	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1206	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3414	106.0	1	SNP	p	R87W	0	.	.	259	261	CGT	758	760	CGT	113;112;113	C,A;G;T	106,1;105;102	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1206	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3414	106.0	1	SNP	p	S87R	1	.	.	259	261	CGT	758	760	CGT	113;112;113	C,A;G;T	106,1;105;102	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1206	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3414	106.0	1	SNP	p	R87I	0	.	.	259	261	CGT	758	760	CGT	113;112;113	C,A;G;T	106,1;105;102	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1206	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3414	106.0	1	SNP	p	S88P	0	.	.	262	264	TCC	761	763	TCC	114;115;115	T;C;C	106;107;108	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	930	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3148	88.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1739	1741	GGC	105;106;106	G;G;C	99;98;99	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1493	1495	GCA	138;138;139	G;C,A;A	126;128,1;128	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1496	1498	ATC	141;141;141	A;T;C	129;125;127	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1508	1510	GTG	141;142;144	G;T;G	131;128;125	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1508	1510	GTG	141;142;144	G;T;G	131;128;125	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2012	2014	ACC	110;110;109	A;C;C	95;96;99	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2066	2068	GCG	99;101;102	G;C;G	89;84;84	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2066	2068	GCG	99;101;102	G;C;G	89;84;84	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2189	2191	AGC	98;98;98	A;G;C	85;84;86	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2198	2200	GGC	101;100;99	G;G;C,T	88;90;86,1	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	892	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2807	94.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2216	2218	CCG	100;99;99	C,T;C;G	78,1;86;84	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1302	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3756	104.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1989	1991	CCG	119;119;119	C;C;G	103;108;110	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	588	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2398	73.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	877	877	C	93	C	89	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	617	619	GAA	171;171;170	G,A;A;A	154,1;154;155	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	866	868	AAC	196;196;197	A;A;C	173;171;175	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	905	907	GAT	197;195;194	G,C;A;T	177,1;173;176	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1028	1030	TCA	188;188;190	T;C;A	167;165;168	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1157	1159	ATC	173;174;174	A;T;C	162;162;164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1388	1390	GGT	148;149;150	G;G;T,C	133;136;136,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1487	1489	GCA	156;156;156	G;C;A	139;140;140	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	846	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2006	125.7	1	SNP	p	G120K	1	.	.	358	360	AAG	863	865	AAG	198;198;197	A;A;G	175;178;175	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2368	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5331	133.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	380	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1592	71.6	1	SNP	p	V57M	1	.	.	169	171	ATG	780	782	ATG	154;154;154	A;T;G	137;139;138	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
